Insulet Corporation
Insulet Corporation (PODD) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PODD · as of Jun 8, 2026
Key Statistics
Explore Insulet Corporation Data
podd stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 50 · Buy rate: 70.0%
The PODD analyst consensus is Buy, based on ratings from 50 Wall Street analysts over the past 3 months. The average 12-month price target is $227.00, representing +48.15% upside from the current price of $153.22.
Competitors & Peers
podd competitorsPODD
BIIB
DGX
DXCM
LH
PHGStock Performance
Full HistoryAbout Insulet Corporation
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device …
what is insulet corporation · podd stock overview · insulet corporation company profile · who is insulet corporation ceo · podd NASDAQ · insulet corporation headquarters · insulet corporation business segments
About Stock Overview & Key Data
Insulet Corporation (PODD) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since May 15, 2007. As of the latest trading session, PODD stock price is $153.22, with a market capitalization of $10.6B. The stock has returned -49.87% over the past 12 months and -46.09% year-to-date.
According to 50 Wall Street analysts, the consensus rating for Insulet Corporation stock is Buy, with an average 12-month price target of $227.00. In fiscal year 2025, Insulet Corporation reported revenue of $2.7B and net income of $247.1M. For detailed data — including Insulet Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Insulet Corporation (PODD) stock price is $153.22. The stock is traded on NASDAQ under the ticker symbol PODD. The 52-week range is $140.63 – $354.88.